Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sarra Riahi"'
Autor:
Ramon Roozendaal, Jeroen Tolboom, Anna Roos, Sarra Riahi, Jessica Theeuwsen, Miriam V Bujny, Vincent Klaren, Hans J W M Korse, Liesbeth Dekking, Arijan Grootenhuis, Gerrit Jan Weverling, Wouter Koudstaal, Jaap Goudsmit, Katarina Radošević
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103550 (2014)
Current influenza vaccines are believed to confer protection against a narrow range of virus strains. The identification of broadly influenza neutralizing antibodies (bnAbs) has triggered efforts to develop vaccines providing 'universal' protection a
Externí odkaz:
https://doaj.org/article/f72c19910aca492e8f5cc48fa736e993
Autor:
Sarra Riahi, Nizar Ben Moussa, Mohamed Lajnef, Nessrine Jebari, Ali Dabek, Radhouane Chtourou, Grégory Guisbiers, Sophie Vimont, Etienne Herth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49a06e702b4d67642abf008f06f442c5
https://doi.org/10.2139/ssrn.4328040
https://doi.org/10.2139/ssrn.4328040
Autor:
Anna Roos, Joost Vaneman, Sarra Riahi, Katarina Radosevic, Wouter Koudstaal, Jessica Theeuwsen, Jeroen Tolboom, Jaap Goudsmit, Ramon Roozendaal, Liesbeth Dekking
Publikováno v:
Vaccine, 33(14), 1739-1747. Elsevier BV
Background: Current seasonal influenza vaccines are believed to confer protection against a narrow range of virus strains. However, their protective ability is commonly estimated based on an in vitro correlate of protection that only considers a subs
Autor:
Katarina Radosevic, Liesbeth Dekking, Vincent Klaren, Miriam V. Bujny, Arijan Grootenhuis, Gerrit Jan Weverling, Jessica Theeuwsen, Anna Roos, Jaap Goudsmit, Ramon Roozendaal, Sarra Riahi, Wouter Koudstaal, Hans J. W. M. Korse, Jeroen Tolboom
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103550 (2014)
PLoS ONE, 9(7). Public Library of Science
PLoS ONE
PLoS ONE, 9(7). Public Library of Science
PLoS ONE
Current influenza vaccines are believed to confer protection against a narrow range of virus strains. The identification of broadly influenza neutralizing antibodies (bnAbs) has triggered efforts to develop vaccines providing 'universal' protection a